Getting to the top takes hard teamwork.
Zoltan Laboratories have worked, in most cases on a contractual basis, with several
research laboratories in the U.S.A., Hungary, Germany, and France to perform the in
vitro and animal studies as well as produce highly purified and recombinant forms of
PLAP for its programs.
Zoltan Laboratories have also established a collaboration with a Minneapolis-based
firm specialized in expressing human proteins in plants, to produce recombinant PLAP
from tobacco leaves. This new technology will produce humanized PLAP at about 20 to
50-times less cost compared to recombinant PLAP produced by human cells.